Vimarsana
Biggest News Aggregation in the World

Prespecified Analyses News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prespecified Analyses. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prespecified Analyses Today - Breaking & Trending Today

Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial | Chronic Obstructive Pulmonary Disease | JAMA - Vimarsana News

Bisoprolol in Patients With Chronic Obstructive Pulmonary Disease at High Risk of Exacerbation: The BICS Randomized Clinical Trial | Chronic Obstructive Pulmonary Disease | JAMA

This study examines whether the addition of bisoprolol to treatment of people with chronic obstructive pulmonary disease (COPD) at high risk of

Bempedoic Acid Proves Cardiovascular Benefit Across Glycemic Spectrum in New Analysis - Vimarsana News

Bempedoic Acid Proves Cardiovascular Benefit Across Glycemic Spectrum in New Analysis

A prespecified analysis of the CLEAR Outcomes trial assessing outcomes according to glycemic status suggests bempedoic acid provided similar relative benefits across the glycemic spectrum, but the greatest absolute benefits were observed in patients with diabetes.

Esperion Presents Two CLEAR Outcomes Study Late-Breakers at European Society of Cardiology ... - Vimarsana News

Esperion Presents Two CLEAR Outcomes Study Late-Breakers at European Society of Cardiology ...

– In total cardiovascular event analysis, bempedoic acid shows20% risk reductionin MACE-4 and 17% risk reduction in MACE-3–

Esperion Presents Two CLEAR Outcomes Study Late-Breakers at - Vimarsana News

Esperion Presents Two CLEAR Outcomes Study Late-Breakers at

– In total cardiovascular event analysis, bempedoic acid shows 20% risk reduction in MACE-4 and 17% risk reduction in MACE-3 – – In an analysis of...